Open-Label Study Assessment of Safety and Adverse Effects of Subcutaneous Apomorphine Injections in Treating "Off" Episodes in Advanced Parkinson Disease

Published 2008 View Full Article

Authors

Keywords

Journal

CLINICAL NEUROPHARMACOLOGY

Volume 32, Issue 2, Pages 89-93

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2008-10-30

DOI

10.1097/wnf.0b013e31816d91f9

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

CLINICAL NEUROPHARMACOLOGY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Ask a Question. Answer a Question.